Endo Will Seek Oxymorphone ER Label For Opioid-Naïve & -Experienced Patients
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Endo’s upcoming resubmission for extended-release oxymorphone will contain a new study in opioid-naïve patients and an existing study in opioid-experienced patients in hopes of gaining a broad pain relief indication.